Annual report pursuant to Section 13 and 15(d)

Revenues from Contracts and Significant Customers (Narrative) (Details)

v3.23.1
Revenues from Contracts and Significant Customers (Narrative) (Details) - Dermatology Products Sales - Customer Concentration Risk - customer
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue [Member]    
Disaggregation of Revenue [Line Items]    
Number of customers 0  
Accounts Receivable [Member]    
Disaggregation of Revenue [Line Items]    
Number of customers 2 1
One Customer | Accounts Receivable [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage   12.00%
Customer one | Accounts Receivable [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 16.30%  
Customer Two | Accounts Receivable [Member]    
Disaggregation of Revenue [Line Items]    
Concentration risk, percentage 12.90%